Keyphrases
Mortality Risk
100%
Increased Mortality
100%
Antinuclear Antibodies
100%
Antibody Titer
100%
Idiopathic Pulmonary Fibrosis
100%
Antibody Test
25%
Etiology
12%
Old Age
12%
Clinical Significance
12%
Delayed Diagnosis
12%
Prognostic Value
12%
Baseline Characteristics
12%
Patient Management
12%
Potential Confounders
12%
Specific Mortality
12%
Antinuclear Antibody Positivity
12%
Competing Risks
12%
Carbon Dioxide
12%
Forced Vital Capacity
12%
Cox Proportional Hazard Analysis
12%
Lung Transplantation
12%
Interstitial Lung Disease
12%
Diagnosis of Exclusion
12%
Lung Diffusing Capacity
12%
Nursing and Health Professions
Antinuclear Antibody
100%
Antibody Titer
100%
Fibrosing Alveolitis
100%
Proportional Hazards Model
11%
Patient Care
11%
Lung Transplantation
11%
Carbon Monoxide
11%
Forced Vital Capacity
11%
Lung Diffusion Capacity
11%
Interstitial Lung Disease
11%
Medicine and Dentistry
Antinuclear Antibody
100%
Idiopathic Pulmonary Fibrosis
100%
Patient Care
11%
Proportional Hazards Model
11%
Clinical Significance
11%
Carbon Monoxide
11%
Forced Vital Capacity
11%
Interstitial Lung Disease
11%
Lung Transplantation
11%
Lung Diffusion Capacity
11%
Diagnosis of Exclusion
11%
Pharmacology, Toxicology and Pharmaceutical Science
Antinuclear Antibody
100%
Fibrosing Alveolitis
100%
Carbon Monoxide
11%
Interstitial Lung Disease
11%
Biochemistry, Genetics and Molecular Biology
Titer
100%
Lung Diffusion Capacity
20%
Forced Vital Capacity
20%